NCT04552067View on ClinicalTrials.gov

Enoxaparin Bioequivalence Study in Acute Coronary Syndrome Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

January 31, 2014

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Lovenox

patients given curative dose of Lovenox

DRUG

Enoxaparin

patients given curative dose of Enoxa

Trial Locations (1)

5000

Emergency Department of University Hospital of Monastir, Monastir

All Listed Sponsors
collaborator

University Hospital Fattouma Bourguiba

OTHER

lead

University of Monastir

OTHER

NCT04552067 - Enoxaparin Bioequivalence Study in Acute Coronary Syndrome Patients | Biotech Hunter | Biotech Hunter